News Release: July 25, 2025
2-Bromopyrimidine Price, Production, Latest News and Developments in 2025
Link to full report: 2-Bromopyrimidine price trend and production News
2-Bromopyrimidine Price Trend in Past Five Years and Factors Impacting Price Movements (2019–2024)
The global 2-Bromopyrimidine price trend has experienced fluctuations over the past five years due to shifting raw material costs, supply chain bottlenecks, geopolitical events, and varying levels of demand from key industries, especially pharmaceuticals and agrochemicals.
In 2019, 2-Bromopyrimidine was priced at around $2,800/MT. During this period, stable supply chains and low-cost bromine derivatives helped keep costs in check. However, a moderate uptick in demand from the pharmaceutical intermediate sector began to push the prices up slightly in the latter half of the year.
By early 2020, the outbreak of COVID-19 led to major disruptions in global logistics. Prices surged to $3,400/MT due to production shutdowns in China and India, two of the largest producers of 2-Bromopyrimidine. Additionally, increased freight charges and delays in customs clearance contributed to market uncertainty.
In 2021, prices saw some stability in the first half of the year, averaging $3,150/MT, but raw material volatility pushed prices again in Q3 to over $3,500/MT. Supply recovery was inconsistent, and bromine prices rose steeply. An increase in energy prices due to post-pandemic industrial revival further added cost pressure on 2-Bromopyrimidine production.
During 2022, the Russia-Ukraine conflict added further uncertainty to energy and chemical supply chains. Prices peaked around $3,800/MT in Q2 due to severe shortages and a surge in demand from North America and Europe. Additionally, regulatory constraints in China and tightened environmental checks limited the production capacity of some major manufacturers.
In 2023, a gradual normalization of logistics and a balancing of demand-supply led to minor corrections. The average price for the year was around $3,600/MT. New capacity additions in Southeast Asia and increased export volumes from India helped ease the global 2-Bromopyrimidine price trend. Still, sustained demand from pharmaceutical R&D and agricultural chemistry kept the market tight.
Entering 2024, the price started around $3,550/MT and remained relatively stable due to predictable demand. Production facilities upgraded with better bromination technologies allowed higher yield efficiencies, slightly reducing production costs. However, bromine raw material shortages in Q3 led to a temporary price spike of around $3,900/MT.
Overall, key factors impacting the 2-Bromopyrimidine price news in the past five years have included:
- Fluctuations in bromine and pyrimidine base compound prices
- Regulatory tightening in major production regions
- Freight rate volatility and port congestions
- Seasonal demand from agrochemical sectors
- Pharmaceutical research spending, especially post-COVID
2-Bromopyrimidine Price Trend Quarterly Update in $/MT – 2025 (Estimates)
Here is an estimated quarterly update of 2-Bromopyrimidine price news in 2025:
- Q1 2025: $3,700/MT
- Q2 2025: $3,650/MT
- Q3 2025: $3,850/MT (due to seasonal uptick in agrochemical production)
- Q4 2025: $3,600/MT
The slight elevation in Q3 is anticipated due to high demand from crop protection chemical manufacturers during pre-harvest seasons in North America and Asia-Pacific. Prices are expected to normalize in Q4, supported by increased production capacities coming online in India and Malaysia. The overall 2-Bromopyrimidine price trend in 2025 is likely to remain moderately bullish due to firm demand fundamentals, although increased competition among suppliers may place mild downward pressure on prices in certain regions.
Global 2-Bromopyrimidine Import-Export Business Overview
The global import-export market for 2-Bromopyrimidine has evolved significantly over the past decade, becoming increasingly competitive as multiple emerging economies ramp up production to meet rising global demand. This chemical is primarily used in the synthesis of active pharmaceutical ingredients (APIs) and in developing advanced crop protection agents. Due to this, countries with high pharmaceutical and agrochemical manufacturing footprints are the major consumers and importers.
In 2025, China remains the world’s leading exporter of 2-Bromopyrimidine, accounting for nearly 45% of global exports. Chinese manufacturers benefit from economies of scale and well-established bromine supply chains. However, increasing environmental compliance requirements and stricter emission controls have led to supply restrictions in certain provinces, resulting in periodic supply gaps. These restrictions directly influence the global 2-Bromopyrimidine sales volume and lead to periodic price hikes.
India has emerged as a major hub for 2-Bromopyrimidine production and export over the past few years. With improved technological capabilities, Indian manufacturers now contribute nearly 25% of global exports. Government incentives under the “Make in India” initiative have played a key role in increasing investment in brominated compound production. In 2025, Indian exports of 2-Bromopyrimidine are expected to grow by 8% YoY, driven by increasing demand from Europe, Japan, and South Korea.
The European Union, particularly Germany, the Netherlands, and Belgium, represents a major import market for 2-Bromopyrimidine. The region’s stringent pharmaceutical and agrochemical regulatory frameworks have driven demand for high-purity intermediates. However, limited in-house production and high energy costs make Europe reliant on imports, primarily from Asia.
North America, led by the United States, is also a significant importer. Demand is largely driven by pharmaceutical contract manufacturing organizations (CMOs) and advanced research labs. In 2025, the U.S. is expected to import over 2,000 MT of 2-Bromopyrimidine, an increase of 6% from 2024. Trade agreements and lower tariffs on pharmaceutical intermediates have facilitated smoother import flows into the U.S. market.
Japan and South Korea have seen rising demand due to their growing specialty chemical and biotechnology sectors. While domestic production exists, much of the 2-Bromopyrimidine requirement is still met through imports, particularly from India and China. South Korea, in particular, is witnessing increased consumption due to expansion in its local pharmaceutical sector.
On the other hand, countries in Latin America and Africa have limited participation in the global 2-Bromopyrimidine trade. Their import volumes are low and mostly dictated by small-scale pharmaceutical industries. Brazil and South Africa are notable markets, but their contribution to global trade remains marginal.
Exporters are increasingly optimizing their logistics strategies to navigate complex shipping routes and customs compliance. In 2025, sea freight continues to dominate the transportation mode, but air freight is used selectively for high-purity, small-quantity shipments.
Some key trade developments in 2025 that are shaping the 2-Bromopyrimidine news include:
- New bilateral trade agreements between India and the EU enhancing chemical export incentives
- Customs reforms in ASEAN countries facilitating faster chemical clearances
- Rising adoption of digital customs clearance and blockchain in international trade
In terms of challenges, importers in the EU and North America are still facing regulatory scrutiny on trace impurities and origin certifications, which often delay cargo clearances. For exporters, currency volatility and rising freight charges pose risks to profitability.
The overall global 2-Bromopyrimidine production and trade outlook for 2025 remains optimistic. Strong pharmaceutical pipeline developments, a shift towards greener bromination technologies, and strategic manufacturing partnerships between Asian and Western firms are all likely to fuel stable growth.
To get access to comprehensive data on production volume, export shares, supplier profiles, and regional demand breakdowns, request the full sample here:
2-Bromopyrimidine price trend and production News
2-Bromopyrimidine Production Trends by Geography
The global production landscape for 2-Bromopyrimidine has evolved significantly over recent years, primarily due to growing demand in the pharmaceutical and agrochemical sectors. As a brominated heterocyclic compound, 2-Bromopyrimidine is valued for its use as an intermediate in drug and pesticide synthesis. Various regions have developed production capacities based on raw material availability, labor cost structures, industrial infrastructure, and regulatory frameworks. In 2025, the geographical distribution of production continues to highlight Asia-Pacific as the leading hub, with growing contributions from other regions.
China remains the undisputed leader in 2-Bromopyrimidine production, accounting for nearly 40–45% of global output. The country has a well-established chemical manufacturing ecosystem, supported by abundant raw material availability, particularly bromine. Several industrial zones in Jiangsu, Zhejiang, and Shandong provinces host large-scale chemical plants dedicated to halogenated intermediates. In recent years, tighter environmental regulations have caused some disruptions in Chinese output, especially during inspection periods. However, the government has also supported the chemical sector through the modernization of old plants and relocation of production units to chemical parks, which has sustained output levels.
India has seen a substantial rise in 2-Bromopyrimidine production, driven by cost competitiveness and growing global demand for pharmaceutical intermediates. India contributes around 20–25% of global production. Regions such as Gujarat, Maharashtra, and Telangana have become hotspots for specialty chemical manufacturing. The country’s flexible environmental framework, lower labor costs, and increasing investment in chemical R&D make it a preferred location for contract manufacturing. Indian producers are also focusing on exports, with capacity expansions aimed at serving markets in Europe and North America.
Japan has a niche but highly advanced 2-Bromopyrimidine production setup, catering primarily to its domestic pharmaceutical and fine chemical sectors. Though not a major volume producer, Japan is known for producing high-purity material suited for sensitive API manufacturing. The production processes here are highly automated and compliant with international GMP standards. Companies invest heavily in innovation and process optimization, which makes Japanese 2-Bromopyrimidine highly sought-after despite its premium pricing.
South Korea has made steady progress in the brominated intermediates market, including 2-Bromopyrimidine. With a strong emphasis on electronics, chemicals, and biotechnology, South Korea’s chemical sector is growing, and companies are now entering niche segments such as pyrimidine derivatives. The country offers strong export infrastructure and maintains trade relations with Europe, Southeast Asia, and the U.S., allowing for flexibility in distribution.
Europe produces limited volumes of 2-Bromopyrimidine due to high production costs and strict environmental regulations. Countries like Germany and Belgium host small-scale production units, mainly serving high-purity niche applications. However, Europe remains a significant importer of this chemical, relying heavily on Asian suppliers. Despite this, several EU-based chemical companies have invested in backward integration to ensure supply security, and pilot-scale plants have emerged in recent years for specific customer needs.
The United States has minimal domestic production capacity for 2-Bromopyrimidine, relying instead on imports, primarily from China and India. The focus in the U.S. is largely on downstream manufacturing of final pharmaceutical products and custom synthesis. However, a few specialty chemical producers have initiated small-scale domestic production to reduce dependency on foreign sources and enhance supply chain resilience. The “onshoring” trend is expected to drive limited but strategic growth in U.S.-based production in the coming years.
Southeast Asian countries, particularly Malaysia and Thailand, are now entering the 2-Bromopyrimidine production map. These regions benefit from relatively low production costs, improving regulatory environments, and proximity to bromine reserves. With increasing interest from multinational chemical companies to diversify their supply chains beyond China and India, Southeast Asia is expected to expand its role in global production over the next five years.
Latin America and Africa currently contribute negligible volumes to 2-Bromopyrimidine production. However, ongoing feasibility assessments in Brazil and South Africa suggest that localized production may commence in the next few years if demand continues to rise from regional pharmaceutical companies.
In summary, 2-Bromopyrimidine production is heavily concentrated in Asia, with China and India leading the way. While developed economies are more focused on downstream applications and imports, emerging markets are capitalizing on cost advantages and chemical industry growth to expand production capacities. Technological upgrades, regulatory policies, and trade relationships will continue to shape the production dynamics across these geographies.
2-Bromopyrimidine Market Segmentation
The global 2-Bromopyrimidine market is segmented based on various factors such as:
- Application
- Pharmaceutical Intermediates
- Agrochemical Intermediates
- Chemical Research
- Specialty Chemicals
- End-Use Industry
- Pharmaceuticals
- Agriculture
- Chemical Synthesis & Research
- Biotechnology
- Purity Level
- <98%
- ≥98% – ≤99.5%
- 99.5%
- Distribution Channel
- Direct Sales (B2B)
- Distributors & Traders
- Online Chemical Marketplaces
- Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Application-based Segmentation
The dominant application segment is pharmaceutical intermediates, accounting for over 60% of the global market share. 2-Bromopyrimidine serves as a critical building block in the synthesis of antiviral, anti-inflammatory, and anticancer drugs. Its role in the formation of heterocyclic compounds makes it indispensable in drug development. As global pharma R&D spending increases and more generic drug production ramps up, demand from this segment continues to grow steadily.
Agrochemical intermediates represent the second-largest segment, contributing to nearly 25% of the overall demand. The compound is used in the synthesis of herbicides, fungicides, and insecticides. Rising concerns about crop protection and food security are driving agrochemical innovation, which in turn boosts the demand for pyrimidine-based intermediates.
Chemical research and specialty chemicals make up the rest of the application spectrum. Universities, CROs, and chemical manufacturers engaged in experimental synthesis and novel compound development require small but high-purity volumes of 2-Bromopyrimidine. These niche markets are characterized by lower volumes but higher profit margins.
End-Use Industry Segmentation
Among end-use industries, the pharmaceutical sector remains the most significant consumer, driven by drug pipeline expansion, generic drug production, and API manufacturing. North America, Europe, and Asia-Pacific are key pharmaceutical markets influencing demand.
The agriculture sector is the second-largest consumer. As demand for sustainable and effective crop protection chemicals grows, the use of 2-Bromopyrimidine as an intermediate in the production of next-gen agrochemicals is gaining traction.
The chemical synthesis and research segment includes academic institutions and contract research organizations. While the volume consumed is limited, the growth is steady due to increasing government and private investments in chemical innovation.
Purity Level Segmentation
Purity level is a major differentiator in pricing and end-use applicability. The >99.5% purity segment is critical for pharmaceutical-grade synthesis. Buyers in this category include multinational drug manufacturers and research labs. This segment demands strict quality assurance and compliance.
The ≥98% to ≤99.5% purity segment is suited for less sensitive applications, including agrochemical and bulk chemical intermediates. This segment is growing due to expanding crop protection requirements.
Purities <98% are used mainly in experimental and pilot-scale chemical synthesis, where absolute purity is not a primary requirement.
Distribution Channel Segmentation
In terms of distribution, direct sales (B2B) account for the largest share. Manufacturers of 2-Bromopyrimidine often enter into long-term contracts with pharmaceutical and agrochemical companies. This ensures demand stability and price negotiations.
Distributors and traders play a key role in regions with fragmented demand. They serve as intermediaries between producers and smaller buyers who require lower volumes or are unable to engage in direct procurement due to regulatory or logistical reasons.
Online chemical marketplaces are a rising trend, especially for lab-grade or research-grade chemicals. These platforms facilitate quick comparisons, sample orders, and customized packaging for global buyers.
Geographical Segmentation
The Asia-Pacific region dominates the market, both in production and consumption. China and India are the major producers, while Japan and South Korea are significant consumers due to their robust pharmaceutical industries.
North America holds a significant share of the consumption market, led by the United States. Demand is driven by the pharmaceutical and biotechnology sectors. However, the region relies heavily on imports from Asia.
Europe follows with substantial demand from Germany, France, and the United Kingdom. Strict regulations increase demand for high-purity variants, and several contract manufacturers operate in this region.
Latin America and Middle East & Africa are emerging markets. Brazil and South Africa are showing signs of increasing demand due to growing pharmaceutical manufacturing capabilities and research activities.